此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Interdisciplinary Counselling in DIAbetes (DIA/01)

Multidisciplinary Counselling Intervention for the Medium-long Term Adoption of a Physically Active Lifestyle and the Reduction of Sedentary Behaviour in People With Diabetes Mellitus

This behavioral intervention study aims to assess physical activity levels and sedentary behavior among individuals with diabetes. It will compare the effectiveness of standard interventions against informational sessions on the benefits of physical activity for achieving changes in behavior and improving quality of life while reducing reliance on healthcare services.

Participants will be divided into 3 groups: one receiving standard care from the diabetology service; one attending three theoretical motor counseling sessions; another engaging in three theoretical motor counseling sessions plus practical counseling supervised by kinesiologist.

The primary objective is to evaluate physical activity levels at 6 and 12 months post-intervention. Secondary objectives include assessing sedentary time, health status, anthropometric measurements, blood pressure, barriers to engaging in physical activity, motivation levels, dietary habits, readiness for lifestyle changes, perceived quality of life, and functional capacities.

研究概览

详细说明

A total of 123 participants, all voluntary and at no cost, will be recruited from the Diabetology clinics of the Complex Structure of Endocrinology and Metabolic Diseases in Perugia. The recruitment process will employ a randomized, non-blinded methodology, enabling the formation of three distinct groups for comparison.

Group 1 will consist of 41 people who have been diagnosed with diabetes mellitus for a minimum of three months. This cohort will receive standard medical care, which encompasses routine monitoring and management of their condition. Alongside this, participants will complete questionnaires designed to assess their health status and lifestyle, as well as undergo evaluations of their functional abilities, which may include tests of strength, mobility, and overall physical capacity. Importantly, members of this group will not receive specific recommendations for engaging in daily physical activity from healthcare providers or kinesiologists. Instead, the guidance provided will be solely theoretical, with no practical motor counseling offered to enhance their physical activity levels.

Group 2 will similarly include 41 people meeting the same three-month diagnostic criteria for diabetes mellitus. These participants will also benefit from standard care, complete questionnaires, and undergo assessments of their functional abilities. However, a key distinction for Group 2 is the provision of recommendations for daily physical activity from both healthcare professionals and kinesiologists. While this group will receive theoretical guidance on the importance of physical activity, they will not receive practical motor counseling to help them implement these recommendations in their daily lives.

Group 3 will feature another set of 41 people, again fulfilling the condition of having a diabetes mellitus diagnosis for no less than three months. In addition to receiving the same standard care, questionnaire administration, and assessments of functional capabilities, participants in this group will also receive recommendations for daily physical activity from their healthcare and kinesiology teams. What sets Group 3 apart is the inclusion of 24 biweekly sessions focused on practical motor counseling, where individuals will engage in structured physical activity programs. This component is designed to provide hands-on, practical guidance that enables participants to actively incorporate physical exercise into their routines, aiming to enhance their overall health and functional abilities.

Through this detailed approach, the study aims to explore the impact of differing levels of prescribed physical activity and support on the functional outcomes of individuals living with diabetes mellitus, contributing valuable insights to the management practices in diabetic care.

研究类型

介入性

注册 (估计的)

123

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • PG
      • Perugia、PG、意大利、06156
        • 招聘中
        • Diabetes Center of the Section of Endocrinology and Metabolism, University Hospital of Perugia
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • diagnosis of T2DM of at least 3 months;
  • age between 25 and 80 years;
  • engagement in insufficient PA (< 150 minutes per week of moderate-intensity PA, according to WHO guidelines);
  • ability to walk independently;
  • 18.5 < BMI (kg/m²) < 40.

Exclusion Criteria:

  • the presence of severe cardiovascular, neurological, or musculoskeletal conditions that contraindicate PA;
  • refusal or inability to provide written informed consent.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Group 1 (n = 41)
Standard care (SC)
实验性的:Group 2 (n = 41)
Standard care + theoretical counseling on physical activity

Participant wil be involved in:

  • Routine assessments: Anthropometric (weight, height, waist circumference) and hematobiochemical parameters (e.g., glycemic and lipid profiles), and systolic and diastolic blood pressure.
  • General information + administration of the IPAQ, PACE, Barriers, Mediterranean Diet, and Quality of Life questionnaires.
  • Body Composition Assessment: BMI, fat mass (FM), fat free mass (FFM), muscle mass, total body water (TBW) and basal metabolism rate (BMR).
  • Non-diagnostic assessment of functional abilities: submaximal tests of strength, muscular endurance, and flexibility.
  • Only 3 sessions (1 per month) of TCPA: the Kinesiologist will inform the patient about the guidelines and the various types of PA, as well as their dose-dependent effects.
实验性的:Group 3 (n = 41)
Standard care + theoretical counseling on physical activity + practical counseling on physical activity

Participant wil be involved in:

  • Routine assessments: Anthropometric (weight, height, waist circumference) and hematobiochemical parameters (e.g., glycemic and lipid profiles), and systolic and diastolic blood pressure.
  • General information + administration of the IPAQ, PACE, Barriers, Mediterranean Diet, and Quality of Life questionnaires.
  • Body Composition Assessment: BMI, fat mass (FM), fat free mass (FFM), muscle mass, total body water (TBW) and basal metabolism rate (BMR).
  • Non-diagnostic assessment of functional abilities: submaximal tests of strength, muscular endurance, and flexibility.
  • Only 3 sessions (1 per month) of TCPA: the Kinesiologist will inform the patient about the guidelines and the various types of PA, as well as their dose-dependent effects.

Participant wil be involved in:

  • Routine assessments: Anthropometric (weight, height, waist circumference) and hematobiochemical parameters (e.g., glycemic and lipid profiles), and systolic and diastolic blood pressure.
  • General information + administration of the IPAQ, PACE, Barriers, Mediterranean Diet, and Quality of Life questionnaires.
  • Body Composition Assessment: BMI, fat mass (FM), fat free mass (FFM), muscle mass, total body water (TBW) and basal metabolism rate (BMR).
  • Non-diagnostic assessment of functional abilities: submaximal tests of strength, muscular endurance, and flexibility.
  • Only 3 sessions (1 per month) of TCPA: the Kinesiologist will inform the patient about the guidelines and the various types of PA, as well as their dose-dependent effects.
  • PCPA: supervised mixed physical activity program (cardiovascular + resistance) lasting 3 months, with 2 sessions per week.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Total weekly physical activity time
大体时间:At the time of enrollment and follow-up (6 and 12 months).

Total physical activity (PA) time in a week, expressed in min/week. It result from the sum of time spent in moderate-intensity PA + time spent in vigorous-intensity PA + time spent in walking.

This measure will be assessed using the International Physical Activity Questionnaire and Actigraphy.

At the time of enrollment and follow-up (6 and 12 months).

次要结果测量

结果测量
措施说明
大体时间
Total weekly walking physical activity time
大体时间:At the time of enrollment and follow-up (6 and 12 months).

Total physical activity (PA) time in a week, expressed in min/week, spent in walking.

This measure will be assessed using the International Physical Activity Questionnaire and Actigraphy.

At the time of enrollment and follow-up (6 and 12 months).
Total weekly moderate physical activity time
大体时间:At the time of enrollment and follow-up (6 and 12 months).

Total physical activity (PA) time in a week, expressed in min/week, spent in moderate-intensity PA.

This measure will be assessed using the International Physical Activity Questionnaire and Actigraphy.

At the time of enrollment and follow-up (6 and 12 months).
Total weekly vigorous physical activity time
大体时间:At the time of enrollment and follow-up (6 and 12 months).

Total physical activity (PA) time in a week, expressed in min/week, spent in vigorous-intensity PA.

This measure will be assessed using the International Physical Activity Questionnaire and Actigraphy.

At the time of enrollment and follow-up (6 and 12 months).
Sedentary time
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Daily time spent in sedentary activities (defined as activities with a energy expenditure <1.5 Metabolic Equivalent of Task-hours). This measure will be assessed using the International Physical Activity Questionnaire and Actigraphy.
At the time of enrollment and follow-up (6 and 12 months).
Age
大体时间:At the time of enrollment.
Number of years of patients
At the time of enrollment.
Body weight
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Weight (kg) assessed using a calibrate medical scale
At the time of enrollment and follow-up (6 and 12 months).
Height
大体时间:At the enrollment, and during follow up (6 and 12 months)
Height (m) assessed using a medical stadiometer.
At the enrollment, and during follow up (6 and 12 months)
Waist circumference
大体时间:At the enrollment, and during follow up (6 and 12 months)
Waist circumference (cm) will be measured using a medical tape
At the enrollment, and during follow up (6 and 12 months)
Body mass index (BMI)
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Body mass index (kg/m2) will be calculated as weight (kg) divided by the square of height (meters).
At the time of enrollment and follow-up (6 and 12 months).
Fasting glucose
大体时间:At the enrollment, and during follow up (6 and 12 months)
Blood glucose value expressed in mg/dl
At the enrollment, and during follow up (6 and 12 months)
Glycated hemoglobin (HbA1c)
大体时间:At the enrollment, and during follow up (6 and 12 months)
Mean of blood glucose in the last three months, expressed in percentage
At the enrollment, and during follow up (6 and 12 months)
Total blood cholesterol value
大体时间:At the enrollment, and during follow up (6 and 12 months)
Total cholesterol value in blood, expressed in mg/dL
At the enrollment, and during follow up (6 and 12 months)
Serum Glutamic-Oxaloacetic Transaminase (SGOT) and Serum Glutamic-Pyruvic Transaminase (SGPT)
大体时间:At the enrollment, and during follow up (6 and 12 months)
SGOT and SGPT blood values
At the enrollment, and during follow up (6 and 12 months)
Creatinine
大体时间:At the enrollment, and during follow up (6 and 12 months)
creatinine blood values, expresseg in mg/dL
At the enrollment, and during follow up (6 and 12 months)
Blood pressure
大体时间:At the enrollment, and during follow up (6 and 12 months)
Systolic and diastolic blood pressure (mmHg) values will be measured with a digital column sphygmomanometer for professional blood pressure measurement.
At the enrollment, and during follow up (6 and 12 months)
Stages of Change
大体时间:At the time of enrollment and follow-up (6 and 12 months).

Stages of Change will be studied using an eight point item questionnaire specifically used for exercise, developed as part of the PACE (Patient-centered Assessment and Counseling for Activity) project.

It is based on the Transthetic Model of Prochaska and Di Clemente and helps understand where a person is with respect to physical activity.

At the time of enrollment and follow-up (6 and 12 months).
Barriers to physical activity
大体时间:At time of enrollment and follow up (6 and 12 months).
This is a 32-item instrument used to identify specific barriers to adherence and maintenance physical activity. Items are grouped into key categories that influence behavior: personal barriers (e.g., laziness, lack of motivation, tiredness, feelings of shame); physical/health barriers (e.g., pain, fear of injury, feeling too fat); environmental/external barriers (e.g., weather conditions, lack of safe places, traffic); social/economic barriers (lack of family support, excessive costs). The list of barriers comes from integrating the "PACE" protocol adapted for diabetic or obese people .
At time of enrollment and follow up (6 and 12 months).
Adherence to the Mediterranean diet
大体时间:At time of enrollment and follow up (6 and 12 months).
Eating habits and adherence to the principles of the Mediterranean diet will be assessed by administering the 14-Item Mediterranean Diet Assessment Tool questionnaire.
At time of enrollment and follow up (6 and 12 months).
Measures of patient's health-related quality of life
大体时间:At time of enrollment and follow up (6 and 12 months).
The 36-Item Short Form Survey (SF-36) evaluates eight health domains (physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health), providing scores for both physical and mental health functioning. Each item is scored on a 0 to 100 range: a lower score indicates higher impairment and a higher score indicates better health.
At time of enrollment and follow up (6 and 12 months).
Self-Care, Usual Activities quality of life, and health status
大体时间:At time of enrollment and follow up (6 and 12 months).
Movement Ability, Personal Care, usual Activities (i.e. Work, Study, Home), Pain or Discomfort, and Anxiety or Depression will be assessed using the EuroQol-5Dimensions-3levels questionnaire. For each dimensions, participants will choose between 3 levels of severity (indicated by numbers 1= No problems; 2=Some / Moderate problems; 3=Extreme problems / Inability to perform the action). Finally, the EQ-VAS will be used to ask participants about health status over the past year. This questionnaire is usually accompanied by a Visual Analog Scale (VAS), a sort of "thermometer" graduated from 0 to 100 on which the patient is asked to mark how they rate their health today.
At time of enrollment and follow up (6 and 12 months).
Hand Grip Strength
大体时间:At time of enrollment and follow up (6 and 12 months).
The Hand Grip Strength will be measured with DynX ® dynamometer.
At time of enrollment and follow up (6 and 12 months).
Dynamic muscle strength
大体时间:At time of enrollment and follow up (6 and 12 months).
Dynamic muscle strength will be assessed by estimating one repetition maximum by submaximal upper and lower limb strength tests, performed at natural load or with the aid of isotonic machines, using Brzycki's 1-RM prediction equation.
At time of enrollment and follow up (6 and 12 months).
Aerobic capacity
大体时间:At the time of enrolment and at 6 and 12 months
Aerobic capacity will be estimated using the 6 Minutes Walking Test.
At the time of enrolment and at 6 and 12 months
Total High-Density Lipoprotein (HDL) values
大体时间:At the enrollment, and during follow up (6 and 12 months)
Total HDL values in blood, expressed in mg/dL
At the enrollment, and during follow up (6 and 12 months)
Total Low-Density Lipoprotein (LDL) values
大体时间:At the enrollment, and during follow up (6 and 12 months)
Total LDL values in blood, expressed in mg/dL
At the enrollment, and during follow up (6 and 12 months)
Triglycerides values
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Triglycerides value in blood, expressed as mg/dL
At the time of enrollment and follow-up (6 and 12 months).
Fat mass value
大体时间:At time of enrollment and follow up (6 and 12 months).
Body fat mass, expressed in kg, assessed using an impedance platform (Tanita Body Composition Analyzer BC-420MA; Tokyo, Japan).
At time of enrollment and follow up (6 and 12 months).
Fat free mass value
大体时间:At time of enrollment and follow up (6 and 12 months).
Body fat free mass, expressed in kg, assessed using an impedance platform (Tanita Body Composition Analyzer BC-420MA; Tokyo, Japan).
At time of enrollment and follow up (6 and 12 months).
Muscle mass value
大体时间:At time of enrollment and follow up (6 and 12 months).
Muscle mass, expressed in kg, assessed using an impedance platform (Tanita Body Composition Analyzer BC-420MA; Tokyo, Japan).
At time of enrollment and follow up (6 and 12 months).
Total body water value
大体时间:At time of enrollment and follow up (6 and 12 months).
Total body water, expressed in percentage, assessed using an impedance platform (Tanita Body Composition Analyzer BC-420MA; Tokyo, Japan).
At time of enrollment and follow up (6 and 12 months).
Basal metabolism value
大体时间:At time of enrollment and follow up (6 and 12 months).
Basal metabolism rate, expressed in kcal, assessed using an impedance platform (Tanita Body Composition Analyzer BC-420MA; Tokyo, Japan).
At time of enrollment and follow up (6 and 12 months).
Fat mass percentage
大体时间:At time of enrollment and follow up (6 and 12 months).
Fat mass percentage assessed using an air plethysmograph (BOD POD® Composition System; COSMED, Albano Laziale, Italy).
At time of enrollment and follow up (6 and 12 months).
Fat free mass percentage
大体时间:At time of enrollment and follow up (6 and 12 months).
Fat free mass percentage assessed using an air plethysmograph (BOD POD® Composition System; COSMED, Albano Laziale, Italy).
At time of enrollment and follow up (6 and 12 months).
Total Sleep Time
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Total Sleep Time, expressed in minutes, measured with the help of portable accelerometers of the ActiGraph Wearable Devices - wGT3X-BT type.
At the time of enrollment and follow-up (6 and 12 months).
Sleep Efficiency percentage
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Sleep Efficiency is a a ratio, expressed as a percentage, representing the proportion of time spent asleep relative to the total time spent in bed. It is calculated as (Total Sleep Time / Time in Bed) × 100. Higher values indicate more consolidated and restorative sleep. It will be measured with the help of portable accelerometers of the ActiGraph Wearable Devices - wGT3X-BT type.
At the time of enrollment and follow-up (6 and 12 months).
Wake After Sleep Onset
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Wake After Sleep Onset is the total amount of time spent awake after initially falling asleep, until the final awakening. It reflects the degree of sleep fragmentation during the night. It will be measured with the help of portable accelerometers of the ActiGraph Wearable Devices - wGT3X-BT type.
At the time of enrollment and follow-up (6 and 12 months).
Sleep Onset Latency time
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Sleep Onset Latency, expressed in minutes, is the time it takes to transition from full wakefulness to sleep after lying down. Longer latency may indicate difficulty initiating sleep. It will be measured with the help of portable accelerometers of the ActiGraph Wearable Devices - wGT3X-BT type.
At the time of enrollment and follow-up (6 and 12 months).
Sleep Fragmentation Index
大体时间:At the time of enrollment and follow-up (6 and 12 months).
Sleep Fragmentation Index is an index that measures the frequency of sleep-wake transitions, expressed as a percentage. It will be measured with the help of portable accelerometers of the ActiGraph Wearable Devices - wGT3X-BT type.
At the time of enrollment and follow-up (6 and 12 months).

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年2月12日

初级完成 (实际的)

2026年1月23日

研究完成 (估计的)

2027年12月31日

研究注册日期

首次提交

2026年4月22日

首先提交符合 QC 标准的

2026年5月6日

首次发布 (实际的)

2026年5月13日

研究记录更新

最后更新发布 (实际的)

2026年5月13日

上次提交的符合 QC 标准的更新

2026年5月6日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅